These results implied that YTHDF2 is a major target protein of THM in pancreatic cancer cells, and YTHDF2 overexpression promoted cell viability and proliferation of TMH-treated cells, whereas YTHDF2 knockdown inhibited their viability. Here, YTHDF2 is linked to pancreatic neoplasm.